Calling Ophthalmologists in training 🤙🏽 👁️ We are taking bookings for the February 2025 Oxford Eye Course! 👁️ An intensive weekend revision course to prepare candidates for success in the FRCOphth Part 2 Oral examination 👁️ Visit to book @RCOphth

RT @amnesty: Month after month, the world has watched as Israel treated Palestinians in Gaza as a subhuman group unworthy of human rights a…

@DurkaDougall @NHSuk @K_and_R_NHS Congratulations - an exciting time ahead.

Next steps: - I will help @RCOphth look again at UK monitoring recommendations in light of post-2020 data - Cost-effectiveness of HCQ screening in the UK can now be more precisely estimated - A repeat study using similar methods could evaluate future screening impact

Caveats: - Direct comparison should examine baseline characteristics & re-treatment criteria (likely similar) - Prior statement is opinion - Approx time to treat all our wAMD patients: - Intravitreal gene therapy: 1 month - Subretinal: several YEARS

RT @DunJackFu: Pegcetacoplan associated with slower growth of photoreceptor degeneration (PRD), RPE-loss, PRD in isolation, and RPE and Out…

Hugely exciting development for the field of retinal gene therapy, giving hope to those living with visual impairment. RPGR-related RP Dry AMD CDHR1 macular/ cone-rod dystrophy Congratulations to all @BeaconTx_

RT @BeaconTx_: We are thrilled to announce the successful closing of our $170 million Series B, led by Forbion, with contributions from Syn…

@LondonEyeDoc @UCLMS @RoyalFreeNHS @RFOphthalmology Many congratulations Prof. Jain

@andrewdick4 @UCLeye Fantastic. Is a recording of the lecture available to view?

@andrewdick4 Congratulations @andrewdick4 and team for this fantastic paper

We are now taking bookings for the next Oxford Eye Course on 12-13th Oct 2024 Visit: to book. 📷Video word cloud from aggregated free text feedback from all our courses to date @RCOphth @EyeNewsMag #Ophthalmology

@BeaconTx_ Link to full-text of paper (available for 50 days):